Acute and recent HIV infection

Size: px
Start display at page:

Download "Acute and recent HIV infection"

Transcription

1 Acute and recent HIV infection Kristien Wouters¹, Ilse Kint¹, Eric Florence¹, Annelies Van Den Heuvel², Katrien Fransen², Olivier Koole¹ and Lutgarde Lynen¹ ¹ Institute of Tropical Medicine, Aids Reference Centre ² Institute of Tropical Medicine, Aids Reference Laboratory

2 Background Every year around 1000 new HIV-infections in Belgium At ITM: % of recent infections and acute seroconversions is increasing? At ITM: lack of standardized definitions and management of acute seroconversion and recent infections among clinicians

3 Objectives To determine the proportion of new and recent HIV infections among recently enrolled HIV+ patients To describe characteristics of those patients with regard to clinical, immunological, virological, behavioral aspects

4 Method Retrospective analysis Review of all new patients diagnosed at ITM ARL and ARC in 2010 Data retrieved from HIV database (ARC and ARL), completed by chart review (each physician) Data: WIV data + HIV test result (P24 Ag, HIV-AB, Inno- LIA bands) + CD4/CD8 + VL + risk behavior + history of STI + symptoms at presentation + last negative test

5 EACS definition acute primary HIV infection: High risk exposure within previous 2-8 weeks And clinical symptoms And detectable HIV (p24ag or HIV-RNA>10,000 copies/ml) And negative or indeterminate serologic Ab testing EACS: European AIDS Clinical Society

6 Results: Patient flow chart

7 Demographic characteristics Sex and sexual orientation Ethnic origin 82; 59% 35; 25% 22; 16% Male Hetero Female MSM 32; 23% 23; 17% 84; 60% Western Europe Sub Sahara Africa other

8 DEFINITIONS USED IN THE ANALYSIS Laboratory seroconversion (LAB): identified by lab (negative bands in LIA) Clinical seroconversion syndrome (CLIN): Clinical symptoms compatible with seroconversion, but already some positive bands in LIA Recent infection (REC): Already some positive bands in LIA, but recent negative test or history of seroconversion syndrome in past 6 months Chronic infection: older than 6M

9 Acute and Recent HIV Number of patients Clinical symptoms High risk contact 2-8w Last neg test <6m LAB CLIN REC CHRON Total 139 Targeting prevention efforts 48/139 acute and recent infections (35%) Male: 94% (45) Origin: Western Europe: 85% MSM: 79%

10 Documented STI in last 3M Total persons with STI NGU Acute HCV Acute HBV LGV Gonorrhoea Chlamydia Syphilis 0% 2% 0% 2% 0% 2% 0% 6% 2% 4% 1% 6% 12% 11% 23% 33% Chronic hiv infection Acute and recent hiv infection 0% 5% 10% 15% 20% 25% 30% 35%

11 How to better identify patients with clinical seroconversion and/or recent infection? Extra laboratory information? Different bands in LIA are still negative or indeterminate in clinical seroconversions and recent infections (gp120, p31, p17) CD8 >= 1500 cells/µl High CD4 count High VL Clinical seroconversion symptoms

12 Limitations Retrospective study Recall bias on sexual risk behavior 1 ARC/ARL

13 Conclusions 1/3 of new HIV+ patients presenting at ITM in 2010 are acute or recent infections Only 1/3 of these are diagnosed through LAB seroconversion parameters (EACS) Combined clinical and laboratory information is needed to identify correctly recent infections

14 Conclusions Patients with recent infections can be a specific group for targeted prevention messages Management of recent infections is still unclear: when to treat 20% of new diagnosis do not present for care in Antwerp what has happened?

15 The way forward Prospective observational study Multicentric Protocol will be submitted in next Breach meeting -> invitation to participate Please contact us:

Update on PrEP BREACH SYMPOSIUM ANDERLECHT, 24 NOVEMBER Bea Vuylsteke, MD PhD Unit HIV & Sexual Health

Update on PrEP BREACH SYMPOSIUM ANDERLECHT, 24 NOVEMBER Bea Vuylsteke, MD PhD Unit HIV & Sexual Health Update on PrEP BREACH SYMPOSIUM ANDERLECHT, 24 NOVEMBER 2017 Bea Vuylsteke, MD PhD Unit HIV & Sexual Health Outline PrEP update on: Be-PrEP-ared study Implementation in Belgium Situation in Europe New

More information

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany

The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political

More information

BHIVA Workshop: When to Start. Dr Chloe Orkin Dr Laura Waters

BHIVA Workshop: When to Start. Dr Chloe Orkin Dr Laura Waters BHIVA Workshop: When to Start Dr Chloe Orkin Dr Laura Waters Aims To use cases to: Review new BHIVA guidance Explore current data around when to start To discuss: Medical decisions, pros and cons Luigi

More information

Breach spring meeting: testing in a low-threshold health care center Bo Defooz, Nathalie Annez, Céline Glorie, Karen Couderé, Xavier de Béthune

Breach spring meeting: testing in a low-threshold health care center Bo Defooz, Nathalie Annez, Céline Glorie, Karen Couderé, Xavier de Béthune Breach spring meeting: testing in a low-threshold health care center Bo Defooz, Nathalie Annez, Céline Glorie, Karen Couderé, Xavier de Béthune Case M. 62-year-old women Ghana Residence permit in Italy

More information

NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM)

NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM) NEW CHALLENGES FOR ACCURATE HIV-1 DIAGNOSIS ALL BELGIAN AIDS REFERENCE LABORATORIES KAROLIEN STOFFELS (ARL VUB STP) & FIEN VANROYE (ARL ITM) 30 NOVEMBER 2018, BRUGGE 0 NEW CHALLENGES FOR ACCURATE HIV-1

More information

Health Protection Surveillance Centre HPSC

Health Protection Surveillance Centre HPSC HPSC TRENDS IN SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 1995 TO 2012 Table of Contents Acknowledgements...3 Key Points...3 Introduction...4 Methods...4 General Trends...5 Chlamydia trachomatis infection...6

More information

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011 HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2011 Health Protection Surveillance Centre, www.hpsc.ie Version 2.1 October, 2012 Table of Contents Acknowledgements... 3 Key Points... 3 Introduction...

More information

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010

HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 2010 HPSC SEXUALLY TRANSMITTED INFECTIONS IN IRELAND, 21 Health Protection Surveillance Centre, www.hpsc.ie Version 1. May 212 Table of Contents Acknowledgements... 5 Key Points... 5 Introduction... 7 Methods...

More information

San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment

San Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment Background and Purpose San Francisco Department of Public Health This syndemics assessment is the first step in developing a sustainable system of primary prevention and clinical care in San Francisco

More information

1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London

1. Africa Centre for Health and Population Studies 2. London School of Hygiene and Tropical Medicine 3. University College London A systematic review of the effects of interrupted antiretroviral interventions for prevention of mother-to-child transmission of HIV on maternal disease progression and survival Naidu KK 1, Mori R 2, Newell

More information

EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE

EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE EPIDEMIOLOGY, CLINICAL FEATURES AND OUTCOME OF ACUTE HEPATITIS C IN HIV-POSITIVE PATIENTS: PRESENTATION OF OUR EXPERIENCE E. Angeli, A. Mainini, C. Atzori, G. Gubertini and G. Rizzardini II Dept. Infectious

More information

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution

More information

Diagnostic Tests for HIV

Diagnostic Tests for HIV Mountain West AIDS Education and Training Center Diagnostic Tests for HIV David Spach, MD Principal Investigator, Mountain West AETC Professor of Medicine, University of Washington Last Updated: June 22,

More information

Source :

Source : 1 2 Source : www.ecdc.europa.eu 3 Collection Form: What data are needed? At a minimum, the number of diagnosed cases, and the population denominator (to give it a context), geographical location, and an

More information

HIV/Sexual Health Clinical Education Session

HIV/Sexual Health Clinical Education Session HIV/Sexual Health Clinical Education Session http://courses.ashm.org.au/hiv/hiv-sexual-health-clinical-education-session/ About These Slide These slides may not be published, posted online, or used in

More information

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set

Sexually Transmitted Infection, including HIV, Health Protection Scotland Slide Set Sexually Transmitted Infection, including HIV, 213 Health Protection Scotland Slide Set Enhanced surveillance systems are employed to give more detailed information on the epidemiology of infectious syphilis

More information

Investigating Unresolved HIV Status during Endpoint Confirmation. Kristen Cummings MTN Virology CORE

Investigating Unresolved HIV Status during Endpoint Confirmation. Kristen Cummings MTN Virology CORE Investigating Unresolved HIV Status during Endpoint Confirmation Kristen Cummings MTN Virology CORE Tuesday, October 29 th, 2013 Outline 1. Process of conducting investigations and resolving HIV status

More information

Choosing the right study design

Choosing the right study design Choosing the right study design Main types of study design Randomised controlled trial (RCT) Cohort study Case-control study Cross-sectional study Case series/case note review Expert opinion BEST QUALITY

More information

Letter of Amendment # 3 to:

Letter of Amendment # 3 to: Letter of Amendment # 3 to: HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected Men Who Have Sex with Men (MSM) in the United States Version 1.0, dated 8 October 2015 DAIDS

More information

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP HIV PrEP in Ireland Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP The HSE Sexual Health and Crisis Pregnancy Programme (SHCPP) and the HIV PrEP working

More information

Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys

Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Understanding the spread of HIV among men who have sex with men in Belgium: results from online and on site special surveys Wim Vanden Berghe ITM HIV/AIDS center Department of Public Health Institute of

More information

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED

HIV and PEP. LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED HIV and PEP LTC Rose Ressner WRNMMC ID staff Oct 2014 UNCLASSIFIED Disclaimer The views expressed in this presentation are those of the speaker and do not reflect the official policy of the Department

More information

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( ) Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies

More information

HIV Prevention Pearls

HIV Prevention Pearls HIV Prevention Pearls Meghan Rothenberger, MD Assistant Professor Division of Infectious Diseases University of Minnesota Director, Youth and AIDS Projects October 27, 2017 Disclosure Information I have

More information

Sexually Transmitted Infection Treatment and HIV Prevention

Sexually Transmitted Infection Treatment and HIV Prevention Sexually Transmitted Infection Treatment and HIV Prevention Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine STI Treatment and HIV Prevention.

More information

Annual Epidemiological Report

Annual Epidemiological Report November 2018 Annual Epidemiological Report 1 HIV in Ireland, 2017 Key Facts There were 492 diagnoses of HIV notified in 2017, a rate of 10.3 per 100,000 population. The HIV rate in Ireland has been relatively

More information

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think?

Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Asymptomatic lymphogranuloma venereum in known HIV positive MSM: is it more common than we think? Mr Daniel Ward 1 Dr Meg Boothby 2 Dr Penny Goold 2 Dr Emma Hathorn 2 1 University of Birmingham, UK 2 Whittall

More information

HIV in Ireland 2016 Report

HIV in Ireland 2016 Report HIV in Ireland 2016 Report Acknowledgements In order to accurately track the HIV epidemic in Ireland and to assess the impact of HIV prevention programmes, it is essential to have good quality surveillance

More information

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016

New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 2016 New Brunswick Report on Sexually Transmitted and Blood Borne Infections, 6 Table of Contents. Introduction.... Methodology... 3. Data Limitations.... Definitions used... 3 5. Overview of STBBI epidemiology

More information

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011 Sexually Transmitted Infection surveillance in Northern Ireland 2012 An analysis of data for the calendar year 2011 Contents Page Summary points. 3 Surveillance arrangements and sources of data.. 4 1:

More information

Annual Epidemiological Report

Annual Epidemiological Report November 218 Annual Epidemiological Report 1 Hepatitis C in Ireland, 217 Key Facts Number of cases, 217: 62 Crude notification rate, 217: 13/1, population The number of notifications of hepatitis C decreased

More information

Genital Tract Infections in HIV- Infected Pregnant Women in South West London

Genital Tract Infections in HIV- Infected Pregnant Women in South West London Genital Tract Infections in HIV- Infected Pregnant Women in South West London A Hegazi, N Ramskill, M Norbrook, E Dwyer, S Milne, B Nathan, S Esterich, A ElGalib, T Morgan, A Barbour, P Hay St George s

More information

Laboratory diagnostics CH/HIV/0052/17/10/2017

Laboratory diagnostics CH/HIV/0052/17/10/2017 Laboratory diagnostics CH/HIV/0052/17/10/2017 This slide set was created by ViiV Healthcare GmbH with great care in order to provide balanced information about ViiV products and / or application areas.

More information

European AIDS Clinical Society (EACS) Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe

European AIDS Clinical Society (EACS) Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe European AIDS Clinical Society (EACS) Guidelines for the Clinical Management and Treatment of HIV Infected Adults in Europe PANEL MEMBERS Nathan Clumeck, Treasurer Chair, Brussels, Belgium Anton Pozniak,

More information

Community oriented studies. New perspectives

Community oriented studies. New perspectives Community oriented studies. New perspectives Swiss HIV Cohort Study Increased Viral Load Suppression in HIV+ Persons on ART Cohort size: 4624 4852 5045 5279 5556 5830 6121 6418 6526 100 Percent of individuals

More information

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc)

Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) Date: 6 January 2012 Draft Report WHO evaluation of HIV 1/2 STAT-PAK (Chembio Diagnostic Systems Inc) WHO Collaborating Centre for HIV/AIDS Diagnostic and Laboratory Support Department of Clinical Sciences

More information

Professor Adrian Mindel

Professor Adrian Mindel Causes of genital ulceration viruses and others Professor Adrian Mindel University of Sydney VIM 16 th August 2012 Outline Definition Causes Epidemiology Diagnosis Definition of genital ulcer A defect

More information

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed

Expression of HIV-1 Markers During Progression of Infection E E E Days Since 1st Bleed Seroconversion OVERVIEW HIV-1 AccuVert TM Seroconversion PRB970 is a 4 member, 1.0 ml per vial panel of undiluted, naturally-occurring plasma samples. members represent serial bleeds collected from a single

More information

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection A Elgalib, A Skingsley, O Dosekun, S Alexander, CYW Tong, JA White. Ali Elgalib Consultant in GUM/HIV

More information

STIs in the Indian Country

STIs in the Indian Country STIs in the Indian Country Multiple STI s and Risk for HIV Ryan Kreisberg, MPH Senior Epidemiologist, PRISM Data Manager Agenda STI/HIV Trends across the US and Arizona STIs in the Indian Country Multiple

More information

ESPnet: An Overview of Electronic Case Reporting using EHRs

ESPnet: An Overview of Electronic Case Reporting using EHRs ESPnet: An Overview of Electronic Case Reporting using EHRs Kevin Cranston, MDiv Assistant Commissioner Director, Bureau of Infectious Disease and Laboratory Sciences Massachusetts Department of Public

More information

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ

Micropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons

More information

The results of the ARTEN study. Vicente Soriano Hospital Carlos III, Madrid, Spain

The results of the ARTEN study. Vicente Soriano Hospital Carlos III, Madrid, Spain The results of the ARTEN study Vicente Soriano Hospital Carlos III, Madrid, Spain Nevirapine: a well-defined efficacy and tolerability profile High efficacy levels 1 3 Well-defined safety profile 4 Favourable

More information

AccuSet Anti-HIV-1 Mixed Titer Performance Panel

AccuSet Anti-HIV-1 Mixed Titer Performance Panel signal to cut-off (s/co) DATA SHEET OVERVIEW PRB205(M3) is a modified 16-member panel originating from Anti- HIV-1 Mixed Titer PRB205(M2). Panel members 3, 5, 6, 17, 21, 22, 23, 24, and 25 from the original

More information

Preliminary results of STI Sentinel Surveillance System in Belgium

Preliminary results of STI Sentinel Surveillance System in Belgium Arch Public Health 2004, 62, 259-270 Preliminary results of STI Sentinel Surveillance System in Belgium by Defraye A 1, Sasse A 1 Abstract Objectives: To determine STI incidence trends. Additional objectives:

More information

MANITOBA HIV REPORT 2015

MANITOBA HIV REPORT 2015 MANITOBA HIV REPORT 2015 The Manitoba HIV Program provides information, specialized care, treatment, and support to approximately 1,250 people living with HIV across the province. The Program has two Winnipeg-based

More information

Scotland s Sexual Health Information, SSHI Health Protection Scotland Slide Set

Scotland s Sexual Health Information, SSHI Health Protection Scotland Slide Set Scotland s Sexual Health Information, SSHI 21 Health Protection Scotland Slide Set Data on positive diagnoses of selected STIs, including HIV, are reported from all microbiological laboratories throughout

More information

STDs among Men who Have Sex with Men (MSM), San Francisco

STDs among Men who Have Sex with Men (MSM), San Francisco STDs among Men who Have Sex with Men (MSM), San Francisco 27 212 Applied Research, Community Health Epidemiology, and Surveillance (ARCHES) Population Health Division San Francisco Department of Public

More information

EHIVQUAL. For use with ehivqual, an electronic web based program for quality of care data collection and review REVIEW PERIOD:

EHIVQUAL. For use with ehivqual, an electronic web based program for quality of care data collection and review REVIEW PERIOD: NEW YORK STATE DEPARTMENT OF HEALTH AIDS INSTITUTE EHIVQUAL QUALITY OF CARE INDICATOR DEFINITIONS* * For use with ehivqual, an electronic web based program for quality of care data collection and review

More information

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4.

Prequalification of In Vitro Diagnostics. WHO PROTOCOL for laboratory evaluation of Combined HIV/Syphilis serology assays. PQDx_150. Version: 4. SOP_ WHO PROTOCOL FOR THE LABORATORY EVALUATION OF COMBINED HIV/SYPHILIS SEROLOGY ASSAYS Prequalification-In vitro Diagnostics Assessment Prequalification of In Vitro Diagnostics WHO PROTOCOL for laboratory

More information

Sexual Health reproduction in reference to treatment as/for prevention

Sexual Health reproduction in reference to treatment as/for prevention Sexual Health reproduction in reference to treatment as/for prevention The reasons for sexual reproductive health for PLHIV The number of people living with HIV (PLWH) continues to rise in the UK The increase

More information

MARION COUNTY HEALTH DEPARTMENT. Healthy people living and playing in healthy communities

MARION COUNTY HEALTH DEPARTMENT. Healthy people living and playing in healthy communities MARION COUNTY HEALTH DEPARTMENT Healthy people living and playing in healthy communities STIs in Marion County 2011-2015 Katarina Ost OPHA 2016 Oregon State University Overview Methodology Marion County

More information

CHERUB Collaborative HIV Eradication of Reservoirs: UK BRC (

CHERUB Collaborative HIV Eradication of Reservoirs: UK BRC ( CHERUB Collaborative HIV Eradication of Reservoirs: UK BRC (www.cherub.uk.net) The effect of time to viral suppression at primary HIV infection on long term immunological recovery BHIVA Spring Conference

More information

STIs: Practical Aspects of Management

STIs: Practical Aspects of Management STIs: Practical Aspects of Management Dr Heather Young FAChSHM DipPH Christchurch Sexual Health heathery@xtra.co.nz 027 343 4963 Sexually Transmitted Infections BACTERIAL STIs: CHLAMYDIA GONORRHOEA SYPHILIS

More information

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa

The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa The Feasibility of HIV Prevention Cohort Studies among Men who have Sex with Men (MSM) in sub-saharan Africa HPTN 075 Protocol Chair: Theo Sandfort New York State Psychiatric Institute and Columbia University

More information

Practical Guidance for Healthcare Workers in Ireland on HIV Pre Exposure Prophylaxis (PrEP)

Practical Guidance for Healthcare Workers in Ireland on HIV Pre Exposure Prophylaxis (PrEP) Practical Guidance for Healthcare Workers in Ireland on HIV Pre Exposure Prophylaxis (PrEP) December 2017 Table of Contents 1. Background and context... 2 2. PrEP in Ireland... 3 2.1 HIV PrEP working group...

More information

VOICE Screening Part 1 Visit. Operational Walkthrough Johannesburg, South Africa November 2008

VOICE Screening Part 1 Visit. Operational Walkthrough Johannesburg, South Africa November 2008 VOICE Screening Part 1 Visit Operational Walkthrough Johannesburg, South Africa November 2008 Protocol Requirements Administrative, Behavioral, and Regulatory Procedures Informed consent for screening

More information

INFECTIOUS SYPHILIS NOTIFICATION FORM

INFECTIOUS SYPHILIS NOTIFICATION FORM INFECTIOUS SYPHILIS NOTIFICATION FORM This is a Schedule 1, Section C disease notifiable to the Medical Officer of Health under Sections 74 and 74AA of the Health Act 1956 using non-identifiable data.

More information

Sexually Transmitted & Blood-Borne Infections in LGL ( )

Sexually Transmitted & Blood-Borne Infections in LGL ( ) Sexually Transmitted & Blood-Borne Infections in LGL (2006 2015) Some Highlights: Chlamydia, Hepatitis C and Gonorrhoea were the sexually transmitted infections with the highest incidences in LGL in 2015.

More information

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015

Bio-behavioural study among MSM in European cities. Think Tank Meeting November 25 th, 2015 Bio-behavioural study among MSM in European cities Think Tank Meeting November 25 th, 2015 Christiana Nöstlinger & Wim Vanden Berghe (WP 8 Prevention) on behalf of the Sialon II Project Group ITM, Antwerp

More information

Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039

Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039 Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039 Ulrika Makuraj, MBBCH University of Witwatersrand Mentor : Sinead Delany-Moretlwe South Africa 17 May 2018 Introduction

More information

Human Immunodeficiency Virus Serology

Human Immunodeficiency Virus Serology Participant No: _ Human Immunodeficiency Virus Serology Survey No: RT :20 Please print the document labelled Clinical Notes & Test Instructions and enter your results via myqap. Kit Information Please

More information

Sialon : bio-behavioural study among MSM in Brussels and other European cities

Sialon : bio-behavioural study among MSM in Brussels and other European cities Sialon : bio-behavioural study among MSM in Brussels and other European cities Wim Vanden Berghe Christiana Nöstlinger ITM, Antwerp Breach symposium, ITM, Antwerp November 27 th, 2015 Massimo Mirandola,

More information

2016 NYS HIV Quality of Care Review

2016 NYS HIV Quality of Care Review 2016 NYS HIV Quality of Care Review A new way forward in four parts Bruce Agins, MD, MPH Medical Director NYSDOH AIDS Institute December 15, 2016 Ending the Epidemic: update! A 3-Point plan announced by

More information

Recent HIV infections- GMHS 2012

Recent HIV infections- GMHS 2012 Recent HIV infections- GMHS 2012 52 new diagnoses of HIV at Gay Men s Health in 2012 19 (37%) were infected within 12 months prior to diagnosis Median age 32 years (range 20-42 years) Country of birth

More information

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE Sandyford Protocols MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE www.hiv-druginteractions.org If you require information on occupational exposure to blood borne viruses, including HIV, please refer to the

More information

PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe?

PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe? PrEP (Pre-Exposure-Prophylaxis) for sub-saharan African migrants in Europe? OFFERING PrEP TO ALL GROUPS AT INCREASED RISK FOR HIV. A RESEARCH AGENDA Jasna Loos HIV and Sexual Health Department of Public

More information

10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest.

10/07/18. Dr. Otilia Mårdh, ECDC. No conflicts of interest. No conflicts of interest. Prevention and control of chlamydia in Europe from data to policies and testing recommendations Dr. Otilia Mårdh, ECDC 15th Congress of the European Society of Contraception and

More information

HIV Basics: Clinical Tests and Guidelines

HIV Basics: Clinical Tests and Guidelines HIV Basics: Clinical Tests and Guidelines ACTHIV 2010 Zelalem Temesgen MD Mayo Clinic Topics Baseline laboratory evaluation Laboratory monitoring through the continuum of care Patients not on antiretroviral

More information

Pre-exposure Prophylaxis for HIV Prevention

Pre-exposure Prophylaxis for HIV Prevention Mountain West AIDS Education and Training Center Pre-exposure Prophylaxis for HIV Prevention Concerns about PrEP: Sexual Behavior and STIs Joanne Stekler, MD MPH May 19, 2016 This presentation is intended

More information

HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech

HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech HIV transmission in the UK within Black African communities: how common is it and how do we prevent it? Dr Valerie Delpech We gratefully acknowledge persons living with HIV, clinicians, health advisors,

More information

Diagnosis and Management of Acute HIV

Diagnosis and Management of Acute HIV Diagnosis and Management of Acute HIV A New HIV Diagnosis is a Call to Action In support of the NYSDOH AIDS Institute s January 2018 call to action for patients newly diagnosed with HIV, this committee

More information

Annual Epidemiological Report

Annual Epidemiological Report Annual Epidemiological Report November 2018 Key Facts 1 Early infectious syphilis in Ireland, 2017 There were 398 confirmed cases of early infectious syphilis (EIS) notified in 2017 The notification rate

More information

One-step screening of active hepatitis C virus infection in the community through dried blood spots

One-step screening of active hepatitis C virus infection in the community through dried blood spots One-step screening of active hepatitis C virus infection in the community through dried blood spots V. Saludes 1,2, C. Folch 2,3, A. Morales-Carmona 4, L. Ferrer 2,3, L. Fernández 2,3, R. Muñoz 2,3, M.

More information

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute PrEP for HIV Prevention Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the PrEP Guideline Raise awareness of PrEP among healthcare

More information

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion

Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Quality of medical services and their impact on the cascade of cares in HIV infection, at national level Roundtable discussion Mariana Mărdărescu MD PhD Adrian Streinu-Cercel MD PhD HC Mike Youle MD PhD

More information

STIs- REVISION. Prof A A Hoosen

STIs- REVISION. Prof A A Hoosen STIs- REVISION Prof A A Hoosen Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria and the NHLS Microbiology Tertiary Laboratory at the Pretoria Academic Hospital Complex

More information

Elizabeth C. Dee, 1,2 Noelle Cocoros, 1 Liisa M. Randall, 2 Hannah Rettler, 2 Mark Josephson, 3 Michael Klompas 1,4

Elizabeth C. Dee, 1,2 Noelle Cocoros, 1 Liisa M. Randall, 2 Hannah Rettler, 2 Mark Josephson, 3 Michael Klompas 1,4 A Framework for Automated Continuum of Care Reporting of Selected Notifiable Diseases using Electronic Medical Record Data: Preliminary Data for HIV in Massachusetts Elizabeth C. Dee, 1,2 Noelle Cocoros,

More information

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs

MSM&TGpopulations. Management in. Sex. Sex. Outline. STIs/HIV. Sex. Sexual fluidity and HIV. Risk behavior. Recreational drugs Outline MSM = (at least) 9 patients /day Management in MSM&TGpopulations OPASSPUTCHAROEN M.D. CHULALONGKORNUNIVERSITY BANGKOK, TH /HIV Recreational drugs ual fluidity and HIV Risk behavior AIDS Patient

More information

Lookback studies to assess viral risks The French experience

Lookback studies to assess viral risks The French experience Lookback studies to assess viral risks The French experience 2000-2012 S Laperche 1, MF Leconte des Floris 2, J Pillonel 3, L Hauser 2, C Lefort 2, JY Py 2, I Hervé 2, R Djoudi 2 For the French haemovigilance

More information

ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer

ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer ISBT WP-TTID Annual Report for Subgroup on Virology Drs. Michael Busch, Kurt Roth and Susan Stramer Questionnaire on NAT Screening of Blood Donations for an International Forum on 10 years of NAT Screening

More information

Child sexual abuse and links to HIV and orphanhood in urban Zimbabwe

Child sexual abuse and links to HIV and orphanhood in urban Zimbabwe Child sexual abuse and links to HIV and orphanhood in urban Zimbabwe Presented by: Eunice Lyn Garura Outreach & Training Manager, Family Support Trust, Zimbabwe Analysis by: I Birdthistle, S Floyd & JR

More information

ONLINE SUPPLEMENTARY MATERIALS: FILE 1

ONLINE SUPPLEMENTARY MATERIALS: FILE 1 ONLINE SUPPLEMENTARY MATERIALS: FILE 1 Clinical care pathways using chlamydia and gonorrhoea tests are evolving: point of care nucleic acid amplification tests may reduce genitourinary medicine service

More information

Table S1. Number of eligible individuals by cohort, HIV-CAUSAL and CNICS Collaborations,

Table S1. Number of eligible individuals by cohort, HIV-CAUSAL and CNICS Collaborations, Cohort Table S1. Number of eligible individuals by cohort, HIV-CAUSAL and CNICS Collaborations, 2000-2013 No. of antiretroviraltherapy naïve individuals No. initiated cart regimen in 2000 or later No.

More information

Monitoring Recent HIV Infection in Ireland, 2017

Monitoring Recent HIV Infection in Ireland, 2017 Monitoring Recent HIV Infection in Ireland, 2017 January 2019 Key Facts 1 13% of HIV diagnoses in 2017 (of those tested) were likely to be recent infections (within 4 months), using the Recent Infection

More information

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide

Outline. AIDS & HIV in the Travis County. Global estimates for adults & children end HIV incidence worldwide Outline AIDS & HIV in the Joshua Vest Epidemiologist Austin/ Health & Human Services Department Worldwide HIV/AIDS surveillance National Prevalence Trends Disparities Mortality Modes of exposure Risk factors

More information

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town

HOPE Follow-Up Algorithm: Unusual Cases. Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town HOPE Follow-Up Algorithm: Unusual Cases Urvi Parikh, PhD MTN Virology Core Regional Meeting Lab Breakout Sept 27-28, 2016, Cape Town MTN-025 Testing Algorithm Screening/Enrollment MTN-025 Testing Algorithm

More information

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD February 2014 Objectives Recognize importance of disease syndemics To review current provincial trends: HIV AIDS Infectious syphilis Chlamydia

More information

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX

Survey questionnaire on STI. surveillance, care and prevention. in European countries SAMPLE APPENDIX European Surveillance of Sexually Transmitted Infections Survey questionnaire on STI surveillance, care and prevention in European countries APPENDIX Detailed questionnaire on clinician and laboratory

More information

EQuIP 5 - This version June 2011 Revision Due June 2014

EQuIP 5 - This version June 2011 Revision Due June 2014 Preamble Rockingham Peel Group Non-Occupational Post-Exposure Prophylaxis (NPEP) To Prevent HIV in Western Australia Protocol The purpose of this protocol is to clarify the appropriate use and methods

More information

Il percorso sulla diagnosi del carcinoma anale. Cristina Mussini

Il percorso sulla diagnosi del carcinoma anale. Cristina Mussini Il percorso sulla diagsi del carcima anale Cristina Mussini Standardized Incidence Ratio (SIR) of AIDS-defining cancers in 99.309 pts with HIV/AIDS from French registry-linkage study in different cart

More information

JMSCR Vol 3 Issue 10 Page October 2015

JMSCR Vol 3 Issue 10 Page October 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x DOI: http://dx.doi.org/10.18535/jmscr/v3i10.12 Seroprevalance of Hepatitis B and Hepatitis C Virus Infection among HIV Positive Individuals

More information

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia

Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 6//26 Increase in syphilis testing and detection of early syphilis among men who have sex with men across Australia 27-24 Eric P.F. Chow,2, Denton Callander 3,4, Christopher K Fairley,2, Lei Zhang,2, Basil

More information

Additional North Carolina Projects

Additional North Carolina Projects Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)

More information

STI Indicators by STI

STI Indicators by STI STI Indicators by STI Table of Contents pg. 2 Sexual History pg. 3-4 Syphilis pg. 5-6 Gonorrhea pg. 7-9 Chlamydia pg. 10 HIV/PrEP 1 Sexual History Comprehensive Sexual History Elements Percentage of patients

More information

Strengthening Laboratory Systems for HIV Differentiated Service Delivery

Strengthening Laboratory Systems for HIV Differentiated Service Delivery ADVANCING THE LABORATORY PROFESSION AND NETWORKS IN AFRICA Strengthening Laboratory Systems for HIV Differentiated Service Delivery Anafi Mataka African Society for Laboratory Medicine AIDS 2018 Outline

More information

STOP HIV/AIDS Pilot Project

STOP HIV/AIDS Pilot Project STOP HIV/AIDS Pilot Project QUARTERLY INDICATORS REPORT: 1 April through 30 June 2011 () SUBMITTED TO: The BC Ministry of Health Services SUBMITTED BY: Dr. Rolando Barrios, Dr. Mark Gilbert, Dr. Kate Health,

More information

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital

HIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per

More information